Abstract
During the lifetime, our cells encounter many challenges to their own existence. The survival of organisms and cells depends on the interplay within a complex, yet precisely orchestrated network of proteins. Since the discovery of the Rel/NF-κB family of transcription factors, the research has never come to a stop. These proteins are best known for their key roles played in normal immune and inflammatory responses, also in the control of cellular proliferation, differentiation, apoptosis and oncogenesis. The recent years have witnessed an emerging research regarding NF-κB signalling pathways in aging and senescence as well. In this review we go deeply through NF-κB activity in the modern biogerontology, with the arguments around its possible roles in aging. Nevertheless, a detailed molecular action and mechanism of NF-κB regulation during senescence has yet to be determined. Elucidation of the exact role of NF-κB in aging will be crucial for developing new therapeutic strategies.
Keywords: NF-κB, activation cascades, aging, SNARK, mTOR, sirtuins
Current Drug Metabolism
Title: NF-κB Signature on the Aging Wall
Volume: 11 Issue: 3
Author(s): Doaa Hussein Zineldeen, Hiroaki Uranishi and Takashi Okamoto
Affiliation:
Keywords: NF-κB, activation cascades, aging, SNARK, mTOR, sirtuins
Abstract: During the lifetime, our cells encounter many challenges to their own existence. The survival of organisms and cells depends on the interplay within a complex, yet precisely orchestrated network of proteins. Since the discovery of the Rel/NF-κB family of transcription factors, the research has never come to a stop. These proteins are best known for their key roles played in normal immune and inflammatory responses, also in the control of cellular proliferation, differentiation, apoptosis and oncogenesis. The recent years have witnessed an emerging research regarding NF-κB signalling pathways in aging and senescence as well. In this review we go deeply through NF-κB activity in the modern biogerontology, with the arguments around its possible roles in aging. Nevertheless, a detailed molecular action and mechanism of NF-κB regulation during senescence has yet to be determined. Elucidation of the exact role of NF-κB in aging will be crucial for developing new therapeutic strategies.
Export Options
About this article
Cite this article as:
Hussein Zineldeen Doaa, Uranishi Hiroaki and Okamoto Takashi, NF-κB Signature on the Aging Wall, Current Drug Metabolism 2010; 11 (3) . https://dx.doi.org/10.2174/138920010791196283
DOI https://dx.doi.org/10.2174/138920010791196283 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and Evaluation of Estradiol Derivatives as Anti-Breast Cancer Agents
Letters in Drug Design & Discovery Turning REST/NRSF Dysfunction in Huntingtons Disease into a Pharmaceutical Target
Current Pharmaceutical Design Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Current Drug Targets Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Current Cancer Drug Targets Targeted Pathways in Breast Cancer: Molecular and Protein Markers Guiding Therapeutic Decisions
Current Molecular Pharmacology Approach to the Patient with Subclinical Cushing’s Syndrome
Current Pharmaceutical Design Editorial (Thematic Issue: The Biological Approach to Advanced Cancer: Are We in the Middle of the Road?)
Current Drug Targets Determination of Ethinylestradiol and Levo-Norgestrel Using Microemulsion Electrokinetic Chromatography
Current Analytical Chemistry The Assessment of Some Metabolic Markers by Combination of Ursolic Acid Supplementation and Resistance Training in Young Older Obese Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Carcinogenesis and Therapeutic Strategies in Thyroid Cancer
Current Drug Targets Mathematical Descriptors for the Prediction of Property, Bioactivity, and Toxicity of Chemicals from their Structure: A Chemical-Cum-Biochemical Approach
Current Computer-Aided Drug Design Neuropeptide Y Induces Cardiomyocyte Hypertrophy <i>via</i> Attenuating miR-29a-3p in Neonatal Rat Cardiomyocytes
Protein & Peptide Letters Therapeutic Potential for Thyroid Hormone Receptor-β Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes
Current Vascular Pharmacology HCV-Related Rheumatic Manifestations and Therapeutic Strategies
Current Drug Targets Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design Vitamin D and Lung Cancer
Current Respiratory Medicine Reviews Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Lag of the Proliferative Aging Clock Underlies the Lifespan-Extending Effect of Calorie Restriction.
Current Aging Science Activation of the dsRNA-Activated Protein Kinase PKR in Mitochondrial Dysfunction and Inflammatory Stress in Metabolic Syndrome
Current Pharmaceutical Design Application of Gene Therapy in Diabetes Care
Infectious Disorders - Drug Targets